Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) AI Stock Analysis

• Market Cap: AU$53.17M
• Dividend Yield: N/A
• Average Volume (3M): 103.84K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.57
• Revenue Growth: -6.86%
• EPS Growth: 51.88%
• Country: AU
• Employees: 610
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): <0.01
• Shares Outstanding: 366,642,240
• 10 Day Avg. Volume: 68,103
• 30 Day Avg. Volume: 103,841
• PEG Ratio: 0.08
• Price to Book (P/B): -22.13
• Price to Sales (P/S): 0.36
• P/FCF Ratio: 41.13
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.17
• Price Target Upside: 13.33% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 55 Neutral
• Price Target: AU$0.00 ▼(-100.00% Downside)

The overall stock score is primarily influenced by financial performance, which shows potential for future growth but is currently hindered by significant financial challenges, including persistent net losses and negative equity. Technical analysis indicates mixed signals with short-term bearish trends but some longer-term support. Valuation is weak due to negative earnings and lack of dividends, further impacting the stock's attractiveness.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Business Overview & Revenue Model

Company Description

Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland. It offers services in the areas of appointments, patient records, prescriptions, referrals and fit notes, service improvements, and virtual GP consultations in the form of video and phone. The company provides treatments for allergies, bites and stings, cold and flu, headaches and migraines, joint pains, lifestyle support, mental and sexual health, skin conditions, and stomach and digestive problems, as well as offers virtual healthcare, technology platform licensing, and digital design services. It serves medical insurers, employers, retailers, healthcare providers, and direct sales to the public. The company was incorporated in 2013 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Doctor Care Anywhere generates revenue primarily through its subscription-based model, where patients pay for access to telehealth services and consultations. Key revenue streams include fees from individual consultations, monthly or annual subscriptions for ongoing health services, and partnerships with employers and insurance companies that offer its services as part of employee health benefits. Additionally, the company may earn income from partnerships with healthcare providers and pharmaceutical companies for integrated care solutions and prescription fulfillment services, which contribute to its overall earnings.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Financial Statement Overview

Summary

Doctor Care Anywhere Group PLC exhibits strong revenue and gross profit growth, indicating potential for future profitability. However, persistent net losses and negative equity highlight ongoing financial challenges. The high leverage and negative equity position present significant financial risks. Cash flow improvements are a positive sign, but more progress is needed to ensure long-term financial health and stability.

Income Statement

The company has shown a significant improvement in its revenue growth, increasing from $30.42M in 2022 to $39.33M in 2024, marking a growth trend. The Gross Profit has also increased, but the company is still operating at a loss with a Net Income of -$6.29M in 2024, though this is an improvement from -$22.03M in 2022. EBIT and EBITDA have also improved but remain negative, indicating ongoing operational challenges. Overall, the revenue growth and gross profit improvements are positive, but persistent net losses and negative operating margins indicate ongoing profitability challenges.

Balance Sheet

The balance sheet reveals a negative Stockholders' Equity of -$0.65M in 2024, indicating potential financial instability. The Debt-to-Equity ratio is not meaningful due to negative equity, and the company has a high level of debt ($8.27M) relative to its assets ($14.99M), indicating high leverage. The equity ratio is negative, highlighting financial distress. Despite a reduction in debt from 2023, the negative equity position poses a significant risk.

Cash Flow

Free Cash Flow improved from -$24.38M in 2022 to $0.347M in 2024, indicating improved cash management. The Operating Cash Flow turned positive in 2024 at $0.353M, showing a recovery from previous years' negative cash flows. However, the Free Cash Flow to Net Income ratio remains low, and while operational cash flow has improved, the company's cash position needs further strengthening to ensure sustainability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	36.76M	39.33M	38.46M	29.31M	24.96M	11.57M
Gross Profit	22.57M	22.42M	17.69M	13.42M	10.40M	5.69M
EBITDA	-1.85M	-2.15M	-5.78M	-16.95M	-18.92M	-13.38M
Net Income	-3.15M	-6.29M	-10.05M	-22.03M	-20.22M	-31.28M
Balance Sheet
Total Assets	15.02M	14.99M	19.61M	22.01M	19.69M	27.84M
Cash, Cash Equivalents and Short-Term Investments	4.79M	5.29M	8.10M	5.41M	17.07M	21.60M
Total Debt	8.46M	8.27M	10.79M	1.72M	1.35M	1.49M
Total Liabilities	15.11M	15.64M	17.27M	9.72M	3.86M	2.80M
Stockholders Equity	-89.00K	-645.00K	2.33M	12.29M	15.82M	25.04M
Cash Flow
Free Cash Flow	2.81M	347.00K	-8.67M	-24.38M	-10.10M	-7.02M
Operating Cash Flow	2.82M	353.00K	-6.34M	-22.03M	-8.65M	-6.00M
Investing Cash Flow	-1.99M	-1.65M	-2.24M	-2.34M	-2.42M	698.85K
Financing Cash Flow	-487.00K	-332.00K	9.32M	5.90M	-611.00K	46.79M

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.15
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DOC, the sentiment is Positive. The current price of 0.15 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.17, and above the 200-day MA of 0.11, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 51.83 is Neutral, neither overbought nor oversold. The STOCH value of 62.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:DOC.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DOC	―	AU$53.17M	―	-155.10%	―	-6.86%	51.88%
PCK	―	AU$96.03M	―	-8647.54%	―	25.98%	21.43%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
EMD	―	AU$42.73M	―	-81.30%	―	-36.68%	79.41%
GLH	―	AU$5.87M	-6.71	―	―	-9.90%	34.07%
MDR	―	AU$17.71M	110.00	-240.60%	―	-48.41%	-7200.00%
SHG	―	AU$89.08M	-12.56	―	―	―	―

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Corporate Events

Doctor Care Anywhere Reports Growth in Consultations and Positive Cash Flow in Q3 2025

Doctor Care Anywhere Group PLC reported a 7.5% year-on-year increase in consultations for Q3 2025, driven by new service offerings and platform enhancements. The company maintained positive cash flow with a net operating and investing cash inflow of £0.6 million, marking its second consecutive quarter of positive cash generation. With a strong cash position of £5.4 million, the company is well-positioned for further growth. Management reaffirmed medium-term targets, including revenue doubling over 3–5 years and achieving a 15% EBITDA margin, indicating confidence in its strategic direction.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere to Release Q3 2025 Performance Report

Doctor Care Anywhere Group PLC has announced the release date for its Q3 2025 Appendix 4C report, scheduled for 29 October 2025. This report will update stakeholders on the company’s performance in the third quarter of 2025, which may provide insights into its operational progress and market positioning within the telehealth industry.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Announces Australian Investor Roadshow

Doctor Care Anywhere Group PLC is set to conduct an investor roadshow in Australia from September 15-19, 2025, where key executives will present the company’s H1 FY2025 financial results and discuss strategic priorities in the telehealth sector. This event aims to engage investors by highlighting the company’s growth initiatives, market expansion, and technology innovation, offering insights into its pathway to sustainable growth and shareholder value.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Director Increases Stake in Doctor Care Anywhere Group

Doctor Care Anywhere Group PLC announced a change in the director’s interest, with Director John Stier acquiring an additional 1,000,000 ordinary fully paid Chess Depository Interests (CDIs) through an on-market acquisition. This transaction increases his total holdings to 3,500,000 CDIs, reflecting a significant investment in the company valued at AU$155,000. This move could indicate confidence in the company’s future prospects and may impact stakeholder perceptions positively.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Releases 2025 Interim Report

Doctor Care Anywhere Group PLC has released its interim report for the first half of 2025. The report provides insights into the company’s financial performance and operational updates for the period ending June 30, 2025. This announcement is crucial for stakeholders as it reflects the company’s current market position and future potential in the healthcare industry.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Announces September 2025 Australia Investor Roadshow

Doctor Care Anywhere has announced an investor roadshow in Australia from September 15-19, 2025, where CEO Laura O’Riordan and senior management will present the company’s H1 financial results, business updates, and growth strategy. The roadshow, with events in Sydney and Melbourne, provides investors an opportunity to engage directly with the leadership team, offering insights into the company’s direction and allowing for direct interaction and questions.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Achieves Historic Cash Inflow Milestone in Q2 2025

Doctor Care Anywhere Group PLC reported a significant positive cash inflow of £2.2 million for Q2 2025, marking a historic milestone in its financial performance. The company saw a 1.3% increase in consultations quarter-over-quarter, aligning with management expectations, and continued margin improvements due to cost base transformation and utilization initiatives. With £4.8 million in cash on the balance sheet, the company is poised for further growth, supported by new contracts and ongoing initiatives to broaden its care offerings, despite a year-over-year decrease in consultations due to changes in its secondary care pathway.

The most recent analyst rating on (AU:DOC) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.